“As the world’s first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19, we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.”
Read the full article @ Demiurge Technologies:
“As the world’s first AI-biopharma company that has discovered and publicized the precise aetiology and pathology of COVID-19, we are committed to the non-profit dissemination of our COVID-19 discoveries and the public validation of our COVID-19 clinical predictions.”
Read the full article @ Demiurge Technologies:
“Demiurge is responding to the global outbreak of the 2019 novel coronavirus (COVID-19) through the appropriate use of our AI platform that can make accurate drug discoveries for diseases with limited available clinical data.”
Read the full article @ finanzen.ch:
“Demiurge is responding to the outbreak of the 2019 novel coronavirus (COVID-19) through the appropriate use of our AI platform of discovering novel therapeutic solutions and predicting clinical trial outcomes. We are conducting deep analyses of published studies and clinical data on COVID-19 against our precise broad-spectrum virology models.
In addition to the previous discoveries of multiple PI3K inhibitors as novel therapeutic options for COVID-19, we hereby officially announce further discoveries of the clinical benefits and risks of Remdesivir, Chloroquine, and PI3K inhibitors against COVID-19: […]”
Read the full article @ Demiurge Technologies:
